"It was a very clever sort of con"

"Almost the whole scientific community was conned into thinking — as a consequence of good marketing — that this was a different and better set of drugs. The evidence, as it's all added up, has shown this to be untrue." Dr. Peter Tyrer, a leading psychiatric researcher at Imperial College London

"We have been paying $16 billion a year instead of $2 billion a year for drugs that seem to be no better and might be worse." Douglas Leslie, a researcher at the Medical University of South Carolina

Read the article